If you owned a US iPhone 6 or 7, you may be entitled to a payout Apple has agreed to settle a long-running class-action case in the US ... US owners of iPhone 6, 6 Plus, 6s, 6s Plus, 7, 7 Plus ...

The idea is that you might sometimes hand someone your iPhone to show them something – but don't want them to have total access to your handset. That might especially be the case if you're ...

This update to the iPhone 6 Plus upgrades the camera to 12 megapixels, bumps up the processor power, and adds a pressure-sensitive screen with haptic feedback. Other features are similar to the ...

A pple has a new lineup of great iPhones, and the iPhone 16 Plus is one of the best options for the average user. It brings a ...

Remember when it used to be hard to find cases for the newest model of the iPhone? Now it seems to be the opposite. There is ...

Quickly: Try to turn on your iPhone’s flashlight ... Open the app, tap the plus arrow to create a new shortcut, then add as many steps as you want. When you return to your “Back Tap ...

The best iPhone 16 Plus cases are durable and work seamlessly with the phone's new Action and Camera Control buttons. To help you find the right case for your iPhone 16 Plus, we've assembled some ...

New iPhones usually launch inside Q3 and then get a release date during early Q4 – this has been the case since around 2012 ... know about why people love iPhones so much. The iPhone 6s and iPhone 6s ...

is pleased to announce a decisive legal victory in a trade secrets case brought by I-Mab Biopharma ("I-Mab") in the United States District Court for the District of Delaware. The jury found in ...

Apple on Friday opened a service program for iPhone 6s and 6s Plus models that exhibit issues powering on due to a failed component, the company announced. Apple has ceased sales of the iPhone SE ...

ensuring your iPhone 16 Plus emerges unscathed. The secret to its resilience lies in its hybrid construction. The case combines a shock-absorbing inner layer with a durable hard shell exterior.

I-Mab had initiated the lawsuit on March 1, 2022, alleging that Inhibrx and its Chief Scientific Officer, Brendan Eckelman, Ph.D., improperly accessed and used proprietary information related to ...